ACVA vs. RNAM

Last updated Jun 4, 2026

ACVA (ACV Auctions Inc.) and RNAM (Avidity Biosciences, Inc.) are both stocks. ACVA operates in Software - Application (Technology), while RNAM operates in Biotechnology (Healthcare).

Performance

ACVA vs. RNAM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ACV Auctions Inc. (ACVA) and Avidity Biosciences, Inc. (RNAM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ACVA

• 1D: -8.07%
• 1M: 9.62%
• YTD: -27.56%
• 6M: -26.46%
• 1Y: -64.44%
• 3Y*: -30.73%
• 5Y*: -26.01%
• 10Y*: —

RNAM

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ACVA vs. RNAM - Yearly Performance Comparison

	2026 (YTD)
ACVA ACV Auctions Inc.	23.88%
RNAM Avidity Biosciences, Inc.	0.00%

Fundamentals

Market Cap ACVA : $1.01B RNAM : $10.87B
EPS ACVA : -$0.36 RNAM : -$4.93
PS Ratio ACVA : 1.28 RNAM : 539.42
PB Ratio ACVA : 2.34 RNAM : 6.44
Total Revenue (TTM) ACVA : $781.10M RNAM : $18.76M
Gross Profit (TTM) ACVA : $496.54M RNAM : $14.60M
EBITDA (TTM) ACVA : -$10.72M RNAM : -$741.79M

Return for Risk

ACVA vs. RNAM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACVA

ACVA Risk / Return Rank: 8
ACVA Sharpe Ratio Rank: 7
ACVA Sortino Ratio Rank: 7
ACVA Omega Ratio Rank: 5
ACVA Calmar Ratio Rank: 8
ACVA Martin Ratio Rank: 13

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ACVA vs. RNAM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ACV Auctions Inc. (ACVA) and Avidity Biosciences, Inc. (RNAM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ACVA	RNAM	Difference
Sharpe ratio Return per unit of total volatility	-0.90	—	—
Sortino ratio Return per unit of downside risk	-1.31	—	—
Omega ratio Gain probability vs. loss probability	0.80	—	—
Calmar ratio Return relative to maximum drawdown	-0.86	—	—
Martin ratio Return relative to average drawdown	-1.25	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	ACVA	RNAM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.90	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.43	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.46	—	—

Drawdowns

Drawdown Indicators

	ACVA	RNAM	Difference
Max Drawdown Largest peak-to-trough decline	-88.80%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-75.43%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-82.09%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-84.16%	—	—
Current Drawdown Current decline from peak	-84.31%	—	—
Average Drawdown Average peak-to-trough decline	-59.90%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	51.38%	—	—

Volatility

Volatility by Period

	ACVA	RNAM	Difference
Volatility (1M) Calculated over the trailing 1-month period	27.00%	—	—
Volatility (6M) Calculated over the trailing 6-month period	47.97%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	71.88%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	60.75%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	60.50%	—	—

Dividends

ACVA vs. RNAM - Dividend Comparison

Neither ACVA nor RNAM has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials